Opthea Limited (ASX/NASDAQ: OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including ...
Primary Health Properties PLC (‘PHP’, the ‘Group’ or the ‘Company’), one of the UK’s leading investors in modern primary healthcare facilities, is pleased to announce that following its secondary ...